Case Study: Acepodia achieves FDA 21 CFR Part 11 compliance and faster, secure signatures with Adobe Acrobat Sign

How Adobe Acrobat Sign helps Acepodia comply with FDA regulations

Acepodia is a biopharmaceutical company developing accessible cell therapies using its Antibody-Cell Conjugation (ACC) platform to target cancer more precisely. Working with research partners and contract research organizations across multiple countries, Acepodia needed to replace slow, paper-based agreements with a digital process — but had to ensure electronic documents and signatures met strict FDA requirements, including 21 CFR Part 11.

Adobe Acrobat Sign provided a compliant e-signature solution with audit trails, identity verification, automated routing and strong encryption, letting Acepodia digitize CRO agreements and track status in real time. The change eliminated courier costs, cut document turnaround from weeks to hours, and maintained regulatory compliance, freeing the team to accelerate clinical work and shorten time to market for potential treatments.

Acepodia

Spike Lo

Senior Director Business and Corporate Development